Skip to content

Diphencyprone effect on alopecia areata of eyebrow

Evaluation of efficacy and safety of diphencyprone treatment on alopecia areata of eyebrows of patients referred to Tehran Razi hospital`s diphencyprone clinics in year 1394

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015061520250N1
Enrollment
40
Registered
2015-11-17
Start date
2015-11-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia areata. Alopecia areata

Interventions

Intervention 1: The intervention in this study is topical application of diphencyprone solution on eyebrow by patients. Solution dosage will be determined by a dermatologist. Treatment will be started
Treatment - Drugs
The intervention in this study is topical application of diphencyprone solution on eyebrow by patients. Solution dosage will be determined by a dermatologist. Treatment will be started at 0.0001%-0.00
No intervention

Sponsors

Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 12 to 65 , bilateral eyebrows involvement, the patient's consent to participate in research projects Exclusion criteria: systemic or topical steroid treatment /immunosuppressive therapy (azathioprine , mycophenolate mofetil) and diphencyprone treatment for eyebrows in the past three months, a personal or a family history of vitiligo, history of Koebner positive dermatoses such as psoriasis, pregnancy or lactation, history of liver/kidney/thyroid disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Terminal hair regrowth. Timepoint: Third and sixth months after intervention. Method of measurement: Eyebrow regrowth percentage by comparing patients images.

Secondary

MeasureTime frame
Patient satisfaction following treatment. Timepoint: Third and sixth months after intervention. Method of measurement: Visual analogue scale.;Treatment complications. Timepoint: Every two weeks ( 24 times during the study ). Method of measurement: History taking and physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Sepideh Khani

Razi hospital of dermatology

Drsepideh.khani@gmail.com+98 21 5561 8989

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026